PLSI — Phoenix Life Sciences International Share Price
Last trade - 00:00- $0.00m
- -$0.06m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.36% | ||
| Return on Equity | -71.47% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 28th Feb | Unit | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.02 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Phoenix Life Sciences International Limited is a healthcare solutions company. The Company provides a range of healthcare services to help governments implement diabetes solutions and national healthcare programs. It is primarily engaged in the provision of diabetes management as part of its healthcare services program and approved Phoenix Metabolic rollout. It operates an integrated group of companies for the fulfillment of government-sponsored healthcare service programs, plant-based pharmaceutical production and ongoing research programs. Its healthcare service programs are designed to provide solutions to manage diabetes and other non-communicable diseases (NCD). It partners and produces plant-based pharmaceuticals to treat diabetes, pain, cancer, autoimmune diseases and anxiety and other conditions. Its products include Phoenix Metabolic, Phoenix Auto, Phoenix Calm, Phoenix Daytime, Phoenix Mood, Phoenix Neuro, Phoenix Onco, Phoenix Pain, Phoenix Relax and Phoenix Sleep.
Directors
- Last Annual
- February 28th, 2019
- Last Interim
- February 28th, 2019
- Incorporated
- April 21st, 2009
- Public Since
- December 28th, 2010
- No. of Shareholders
- 269
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 10,084,582
- Address
- 3000 Lawrence St, DENVER, 80205-3422
- Web
- Phone
- +1 7206997222
- Auditors
- BMKR LLP
Upcoming Events for PLSI
Similar to PLSI
Acacia Diversified Holdings
Pink Sheets on Nasdaq
Acusphere
Pink Sheets on Nasdaq
Soul Biotechnology
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 06:17 UTC, shares in Phoenix Life Sciences International are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Phoenix Life Sciences International last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Phoenix Life Sciences International share price has underperformed the S&P500 Index by -9.51% over the past year.
There is no consensus recommendation for this security.
Find out morePhoenix Life Sciences International does not currently pay a dividend.
Phoenix Life Sciences International does not currently pay a dividend.
Phoenix Life Sciences International does not currently pay a dividend.
To buy shares in Phoenix Life Sciences International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Phoenix Life Sciences International had a market capitalisation of $0.00m.
Here are the trading details for Phoenix Life Sciences International:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PLSI
Based on an overall assessment of its quality, value and momentum Phoenix Life Sciences International is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Phoenix Life Sciences International. Over the past six months, its share price has underperformed the S&P500 Index by -3.8%.
As of the last closing price of $0.00, shares in Phoenix Life Sciences International were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Phoenix Life Sciences International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Phoenix Life Sciences International's management team is headed by:
- Lewis Humer - CHM
- Janelle Marsden - CEO
- Geoff Boynton - CFO
- Stephen Cornford - DRC